DBV Technologies | DBVT - Interest Income


DBV Technologies reported $-0.32 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Amarin USD 3.37M 3.37M Dec/2024
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
DBV Technologies USD -0.32 0.02 Sep/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Galectin Therapeutics USD -2.71M 2.77M Dec/2023
Incyte USD 30.75M 3.97M Dec/2025
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
United Therapeutics USD 51.3M 200K Jun/2025